Bristol-Myers Squibb Hero Image
bms_logo_rgb_pos_900x900

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We have a high bar for innovation focused on disease areas with significant unmet need where our medicines can truly make a difference for patients. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome. Each day, our employees around the world work together for patients – it drives everything we do.

430 East 29th Street

New York, NY 10016

 

+1 (212) 546-4000

www.bms.com


RELATED ARTICLES

Alice Walsh Thumbnail

Researcher Profile: Alice Walsh

Alice from Bristol-Myers Squibb shares how she uses data to better inform how we study disease and improve patient care.
 

Mitra Ghandeharizadeh Thumbnail

Living With Limits Does Not Mean Living Without Hope

For Mitra, living with lupus symptoms and limitations doesn’t mean living without hope.

Ryan Moslin Thumbnail

Researcher Profile: Dr. Ryan Moslin

Researchers like Ryan at Bristol-Myers Squibb are making strides in lupus treatment that were impossible 10 years ago.

Lupus Together Pair Thumbnail

In Search of Targeted Treatments for Lupus

Ryan’s research gives Mitra hope that the limitations of her lupus will not last forever.

Fighting Cancer at the Personal Level

Cancer takes 600,000 lives annually in the U.S., but advanced immuno-oncology treatments are making huge differences.

Researcher Profile Nils Lonberg image

Researcher Profile: Nils Lonberg

In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O) treatments.

Translating Science into Valuable Insights to Develop the Next Generation of Personalized Medicines image

Translating Science into Valuable Insights to Develop the Next Generation of Personalized Medicines

Each person’s genetic makeup is unique, and the thousands of treatments and medicines currently available to patients vary in how they impact different subsets of the population.

Tim Reilly image

Researcher Profile: Tim Reilly

As vice president of oncology early asset development at Bristol-Myers Squibb (BMS), Dr. Tim Reilly leads a team of researchers who are pursuing the next generation of medicines to fight cancer.

Do Tumors Hold the Key to Their Own Destruction image

Do Tumors Hold the Key to Their Own Destruction?

By studying the interactions between a tumor and a patient's immune system, researchers at biopharmaceutical companies such as Bristol-Myers Squibb (BMS) are trying to reduce the ambiguity involved in fighting cancer.

How California's Bay Area Biotech Is Advancing Human Health image

How California's Bay Area Biotech Is Advancing Human Health

Nowhere is the partnership between technology and medicine evolving so strongly and quickly than the Bay Area of California.

Targeting the Immune System, Not the Tumor image

Targeting the Immune System, Not the Tumor

Immuno-oncology is based on the concept of harnessing the body's own immune system to fight cancer, and recent scientific discoveries and clinical advances have ushered in a truly historical time in cancer research.